Semba Charles Pauling
SEC insider (Form 3/4/5 filer). CIK 0001872863. Director at DiaMedica Therapeutics Inc. (DMAC). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in MINNEAPOLIS, MN.
Companies Semba Charles Pauling has filed insider reports for
- DiaMedica Therapeutics Inc. (DMAC): Director
Semba Charles Pauling
CIK: 0001872863
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DMAC
DiaMedica Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 1, 2026DMAC
DiaMedica Therapeutics Inc.
AwardDirectStock Option (right to buy)
40.4K shares- - Jan 2, 2026DMAC
DiaMedica Therapeutics Inc.
AwardDirect3.4K shares at avg. $8.42$28K - Jun 1, 2025DMAC
DiaMedica Therapeutics Inc.
AwardDirectStock Option (right to buy)
32.2K shares- - Jan 2, 2025DMAC
DiaMedica Therapeutics Inc.
AwardDirect5.3K shares at avg. $5.34$28K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2026 | DMAC DiaMedica Therapeutics Inc. | Award Stock Option (right to buy) | 40,412 | - | - | Direct |
| Jan 2, 2026 | DMAC DiaMedica Therapeutics Inc. | Award | 3,355 | $8.42 | $28,249 | Direct |
| Jun 1, 2025 | DMAC DiaMedica Therapeutics Inc. | Award Stock Option (right to buy) | 32,162 | - | - | Direct |
| Jan 2, 2025 | DMAC DiaMedica Therapeutics Inc. | Award | 5,290 | $5.34 | $28,249 | Direct |
1-4 of 4 transactions